- Accolade Inc ACCD posted Q3 FY23 sales of $90.95 million, beating the consensus of $87.53 million.
- The company posted an EPS loss of $(0.56), ahead of the consensus of $(0.62), a turnaround from an income of $0.31 a year ago.
- "Accolade enters the new year having just concluded one of the strongest selling performances in our company's history," said Accolade CEO Rajeev Singh.
- For Q4 FY23, the company forecasts sales of $97-$101 million (consensus $101.71 million), with an adjusted EBITDA of $(1)-$3 million.
- For FY23, Accolade expects revenue of $361-$365 million versus the consensus of $359.23 million.
- For FY24, the company expects revenue of about $410 million (consensus $405.39 million).
- Credit Suisse writes that the company has an upside opportunity with the pending T5 contract awards, which could provide a material uplift to revenue and provided some details on plans for achieving EBITDA breakeven in FY25.
- The analyst is incrementally positive on the company's execution against a difficult macro backdrop and remains Neutral on the stock.
- Stifel writes that ACCD's model is highly disruptive and offers the opportunity for both multiple expansion and upward revisions to estimates.
- The analyst says initial guidance provides for deteriorating economic/employment fundamentals even though the company reports relative stability.
- Price Action: ACCD shares are up 25.70% at $9.73 on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in